Muscle creatine phosphate in gyrate atrophy of the choroid and retina with hyperornithinaemia - Clues to pathogenesis

European Journal of Clinical Investigation

Volumn 29, Issue 5, 1999, Pages 426-431

  Heinanen K ^a   Nanto Salonen K ^a   Komu, M ^a   Erkintalo, M ^a   Heinonen, O J ^a,b   Pulkki, K ^b   Valtonen, M ^a   Nikoskelainen, E ^a   Alanen, A ^a   Simell, O ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

31P magnetic resonance spectroscopy; Creatine; Creatine phosphate; Gyrate atrophy; Hyperornithinaemia; Retinitis pigmentosa

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; CREATINE PHOSPHATE; ORNITHINE OXOACID AMINOTRANSFERASE; PHOSPHATE;

ADOLESCENT; ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTROCNEMIUS MUSCLE; GENE MUTATION; HUMAN; HYPERORNITHINEMIA; MALE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RETINA GYRATE ATROPHY; RETINITIS PIGMENTOSA;

ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; GYRATE ATROPHY; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PHOSPHATES; PHOSPHOCREATINE; PHOSPHORUS ISOTOPES; RETINITIS PIGMENTOSA;

EID: 0032932504     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00467.x     Document Type: Article

References (37)

1. 1 Simell O, Takki K. Raised plasma ornithine and gyrate atrophy of the choroid and retina. Lancet 1973; 1: 1031-3.
2. 2 Kaiser-Kupfer MI, Kuwabara T, Askanas V et al. Systemic manifestations of gyrate atrophy of the choroid and retina. Ophthalmology 1981; 88: 302-6.
3. 3 Takki KK, Milton RC. The natural history of gyrate atrophy of the choroid and retina. Ophthalmology 1981; 88: 292-301.
4. 4 Valle D, Simell O. The hyperornithinemias. In. Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular basis of inherited disease, 7th edn. New York: McGraw-Hill; 1995. p. 1147-85.
5. 5 Sipilä I, Simell O, Rapola J, Sainio K, Tuuteri L. Gyrate atrophy of the choroid and retina: tubular aggregates and type 2 fiber atrophy in muscle. Neurology 1979; 29: 996-1005.
6. 6 Valtonen M, Näntö-Salonen K, Heinänen K, Alanen A, Kalimo H, Simell O. Skeletal muscle of patients with gyrate atrophy of the choroid and retina and hyperornithinaemia in ultralow-field magnetic resonance imaging and computed tomography. J Inherit Metab Dis 1996; 19: 729-34.
7. 7 Shapira Y, Yatziv S, Merin S, Statter M, Yarom R. Myopathy in hyperornithinemic gyrate atrophy of choroid and retina. Isr J Med Sci 1981; 17: 271-6.
8. 8 Sipilä I. Inhibition of arginine-glycine amidinotransferase by ornithine. Biochim Biophays Acta 1980; 613: 79-84.
9. 9 Ren J-M, Semenkovich CF, Holloszy JO. Adaptation of muscle to creatine depletion: effect on GLUT-4 glucose transporter expression. Am J Physiol 1993; 264: C146-C150.
10. 10 Walker J. Creatine: biosynthesis, regulation, and function. Adv Enzymol 1979; 50: 177-242.
11. 11 Walker JB. Formaminidine group transfer in extracts of human pancreas, liver and kidney. Biochim Biophys Acta 1963; 73: 241-7.
12. 12 Sipilä I, Simell O, Arjomaa P. Gyrate atrophy of the choroid and retina with hyperornithinemia. Deficient formation of guanidinoacetic acid from ornithine. J Clin Invest 1980; 66: 684-7.
13. 13 Sipilä I, Valle D et al. Low guanidinoacetic acid and creatine concentrations in gyrate atrophy of the choroid and retina (GA). In: De Deyn PP, Marescau N, Stalon V, Qureshi IA, editors. Guanidino compounds in biology and medicine. London: John Libbey; 1992: p.379-83.
14. 14 Sahlin K. Control of energetic processes in contracting human skeletal muscle. Biochem Soc Trans 1991; 19: 353-8.
15. 15 Hultman E, Söderlund K, Timmons JA, Cederblad G, Greenhaff P. Creatine loading in men. J Appl Physiol 1996; 81: 232-7.
16. 31P NMR study. Proc Natl Acad Sci USA 1981; 78: 6714-8.
17. 17 Gadian D, Radda G, Ross B et al. Examination of a myopathy by phosphorus nuclear magnetic resonance. Lancet 1981; 2: 774-5.
18. 18 Garlick PB, Radda GK, Seeley PJ. Studies of acidosis in the ischemic heart by phosphorus nuclear magnetic resonance. Biochem J 1979; 184: 547-54.
19. 31P magnetic resonance. J Biol Chem 1973; 248: 7276-8.
20. 20 Boughman JA, Conneally PM, Nance WE. Population genetic studies of retinitis pigmentosa. Am J Hum Genet 1980; 32: 223-35.
21. 13C NMR spectroscopy in vivo using surface coils. Magn Reson Med 1984; 1: 410-3.
22. 31P nuclear magnetic resonance study. Mol Biol Med 1983; 1: 77-94.
23. 23 Parvy P, Bardet J, Rabier D, Kamoun P. A scheme for the interpretation of primary and secondary disturbances of plasma and urinary amino acid profiles. A possible way to an expert system. Clin Chim Acta 1995; 235: 1-10.
24. 24 Ryschon TW, Fowler MD, Arai AA et al. A multimode dynamometer for in vivo MRS studies of human skeletal muscle. J Appl Physiol 1995; 79: 2139-47.
25. 25 Kemp GJ, Taylor DJ, Dunn JF, Frostick SP, Radda GK. Cellular energetics of dystrophic muscle. J Neurol Sci 1993; 116: 201-6.
26. 31P NMR spectroscopy of metabolic changes associated with muscle exercise: physiological applications. In: Gillies RJ, editor. NMR in physiology and biomedicine. San Diego: Academic Press; 1994: p.389-403.
27. 1. Proc Natl Acad Sci USA 1992; 89: 7521-5.
28. 28 Vandenborne K, Walter G, Ploutz-Snyder L et al. Energy-rich phosphates in slow and fast human skeletal muscle. Am J Physiol 1995; 268: C869-76.
29. 29 Moerland TS, Wolf NG, Kushmerick MJ. Administration of a creatine analogue induces isomyosin transitions in muscle. Am J Physiol 1989; 257 (Cell Physiol 26): C810-6.
30. 30 Holtzman D, Meyers R, O'Gorman E et al. In vivo brain phosphocreatine and ATP regulation in mice fed a creatine analog. Am J Physiol 1997; 272: C1567-77.
31. 31 Argov Z, Bank WJ. Phosphorus magnetic resonance spectroscopy in neuromuscular disorders. Ann Neurol 1991; 30: 90-7.
32. 32 Barany M, Siegel IM, Venkatasubramanian PN, Mok E, Wilbur AC. Human leg neuromuscular diseases: P-31 MR Spectroscopy. Radiology 1989; 172: 503-8.
33. 33 Park JH, Vansant JP, Kumar NG et al. Dermatomyositis: correlative MR imaging and P-31 MR Spectroscopy for quantitative characterization of inflammatory disease. Radiology 1991; 177: 473-9.
34. 31P MR spectroscopy. Radiat Med 1995; 13: 63-5.
35. 35 Ames A. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can J Physiol Pharmacol 1992; 70 (Suppl.): mS158-64.
36. 36 Ames A, Li YY, Heher EC, Kimble CR. Energy metabolism of rabbit retina as related to function: high cost of Na+ transport. J Neurosci 1902; 12: 840-53.
37. 37 Sipilä I, Rapola J, Simell O, Vannas A. Supplementary creatine as a treatment for gyrate atrophy of the choroid and retina. N Engl J Med 1981; 304: 867-70.